Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis Georg Griesinger, Robert Boostanfar, Keith.

Slides:

Advertisements

Similar presentations

Mostafa Metwally, Cynthia M. Farquhar, Tin Chiu Li

Advertisements

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Sesh Kamal Sunkara, Jyotsna Pundir,

Programmes and prospects for ovotechnology

Kay Neumann, Georg Griesinger Reproductive BioMedicine Online

Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,

Donghong He, Fengyan Jiang Reproductive BioMedicine Online

Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response William L. Ledger, Bart C.J.M. Fauser, Paul.

Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial Malin Nylander, Signe Frøssing, Helle V. Clausen,

A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf

Genetic variants associated with female reproductive ageing – potential markers for assessing ovarian function and ovarian stimulation outcome Triin.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Bart C.J.M. Fauser, Michael.

Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction Antonio La Marca, Giovanni D’Ippolito

N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH George Griesinger, Daniel B. Shapiro, Efstratios.

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation Hermann M. Behre, Colin.

Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome Qiong Wang, Lu Luo, Qiong Lei, Ming-Mei Lin, Xuan.

The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis

Factors affecting embryo viability and uterine receptivity: insights from an analysis of the UK registry data Stephen A. Roberts, Mark Hann, Daniel R.

Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective.

Anti-Müllerian hormone as a predictor of pregnancy following IVF

Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of.

Why are reproductive cancers more common in nulliparous women?

Ovarian stimulation protocols for IVF: is more better than less?

Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis Mohan Shashikant Kamath, Richard Kirubakaran, Mariano.

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Sarah McCredie, William Ledger, Christos A. Venetis

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study A. Nasr Reproductive BioMedicine Online

Fertility preservation consultation for women with cancer: are we helping patients make high-quality decisions? Jayeon Kim, Allison M. Deal, Ursula Balthazar,

Prognostic factors influencing fresh and frozen IVF outcomes: an analysis of the UK national database W. Mark Hirst, Andy Vail, Daniel R. Brison, Stephen.

Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis Neelam Potdar, Tarek Gelbaya, Luciano G.

M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber

Impact of ovarian endometrioma on ovarian responsiveness and IVF: a systematic review and meta-analysis Chun Yang, Yuhong Geng, Yanhui Li, Chunyan Chen,

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa F. Olivennes, G. Trew,

Yaniv Zipori, Jigal Haas, Howard Berger, Eran Barzilay

Influence of paternal age on ongoing pregnancy rate at eight weeks' gestation in assisted reproduction Aukje Marieke Meijerink, Liliana Ramos, Kathrin.

Multifetal pregnancy reduction of triplets to twins compared with non-reduced triplets: a meta-analysis Yaniv Zipori, Jigal Haas, Howard Berger, Eran.

Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf

Reproductive Biomedicine & Society Online

Mostafa Metwally, Cynthia M. Farquhar, Tin Chiu Li

Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial Robert Boostanfar, M.D.,

V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss

Michael J. Levy, William Ledger, Efstratios M. Kolibianakis, Pieta C

LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts

Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis IP Kosmas, K Zikopoulos, I Georgiou, E Paraskevaidis, C.

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.

S. Seshadri, S.K. Sunkara, Y. Khalaf, T. El-Toukhy, H. Hamoda

Does ovarian stimulation regimen affect IVF outcome

Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers James D. Stanger, John L. Yovich Reproductive.

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

Pietro Gambadauro, Ramesan Navaratnarajah

The effect of protein supplement concentration in embryo transfer medium on clinical outcome of IVF/ICSI cycles: a prospective, randomized clinical trial

Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature Micah J. Hill, Gary Levy, Eric D. Levens

Response: time-lapse systems for ART

Propofol versus thiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlled trial Evangelia Goutziomitrou, Christos A. Venetis,

Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P

Ovarian reserve screening before contraception?

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH Basil C. Tarlatzis,

Programmes and prospects for ovotechnology

John Yovich, James Stanger, Peter Hinchliffe

Yaniv Zipori, Jigal Haas, Howard Berger, Eran Barzilay

China’s model of egg donation is a policy lesson for Britain

Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study Georg Griesinger, Henriette.

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein

Frequency of low serum LH is associated with increased early pregnancy loss in IVF/ICSI cycles Chin-Der Chen, Yi-Ting Chiang, Po-Kai Yang, Mei-Jou Chen,

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Antonio La Marca, Martina Capuzzo Reproductive.

High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight Suying.

Presentation transcript:

Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis Georg Griesinger, Robert Boostanfar, Keith Gordon, Davis Gates, Christine McCrary Sisk, Barbara J. Stegmann Reproductive BioMedicine Online Volume 33, Issue 1, Pages 56-60 (July 2016) DOI: 10.1016/j.rbmo.2016.04.005 Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Pooled estimates for the differences in oocyte numbers and pregnancy and live-birth rates between corifollitropin and rFSH. *Adjusted for trial, centre, age, and body weight; **Adjusted for trial, region, age, and body weight. P-values describe the test for heterogeneity (P < 0.05 indicates heterogeneous differences across trials). Reproductive BioMedicine Online 2016 33, 56-60DOI: (10.1016/j.rbmo.2016.04.005) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Odds ratios for the development of ovarian hyperstimulation syndrome (OHSS), adjusted for the logistic regression model. P-values describe the test for heterogeneity (P < 0.05 indicates heterogeneous odds ratios across trials). Reproductive BioMedicine Online 2016 33, 56-60DOI: (10.1016/j.rbmo.2016.04.005) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions